FUSION NSE filing

Fusion Finance: Monitoring Agency Report for Q4FY26 Confirms No Deviation in Right Issue Proceeds Utilization

The RealCase readLow impact Neutral

Fusion Finance Limited's Monitoring Agency Report for the quarter ended March 31, 2026, confirms no deviation in the utilization of Rights Issue proceeds. The company raised ₹799.86 crore, with ₹797.29 crore received as of March 31, 2026. ₹382.41 crore was utilized for capital base augmentation, and ₹14.01 crore for issue expenses.

Why it matters

This is a routine compliance filing related to a past fundraising event. It confirms that the company is adhering to the planned utilization of funds, which is expected by investors and regulators. It does not introduce new material information that would significantly impact the company's valuation or stock.

The market read

The announcement is a routine monitoring agency report confirming compliance with the utilization of funds from a previous rights issue. It does not contain any new financial performance data or significant forward-looking statements that would indicate a positive or negative shift.

Fusion Finance Limited has submitted its Monitoring Agency Report for the quarter ended March 31, 2026. The report, issued by CRISIL Ratings Limited, confirms that the utilization of proceeds from the company's Rights Issue has been in line with the disclosures made in the Offer Document, with no deviations observed.

The report was considered by the Audit Committee on May 15, 2026, and is also available on the company's website.

The Rights Issue, which aimed to raise ₹799.86 crore, involved the issuance of partly paid-up equity shares. As of March 31, 2026, the company had received ₹797.29 crore of the total proceeds, with a balance of ₹2.57 crore expected to be recovered through subsequent calls by March 31, 2027.

The net proceeds of ₹783.34 crore were primarily intended for augmenting the capital base to meet future capital requirements arising from business growth and to ensure compliance with capital adequacy ratios. A sum of ₹16.52 crore was allocated for issue expenses.

During the reported quarter, ₹14.01 crore was reimbursed towards issue-related expenses. The total utilized amount for augmenting the capital base stands at ₹382.41 crore, with ₹400.93 crore remaining unutilized as at the end of the quarter. The company intends to deploy the remaining amount in subsequent quarters within the next two fiscal years, as per the offer document.

The unutilized proceeds are deployed in various fixed deposits and bank accounts, including Axis Bank, AU Small Finance Bank, IndusInd Bank, SBI Bank, and Yes Bank, with maturity dates generally in April 2026. The total unutilized amount, excluding the ₹2.57 crore expected from calls, is ₹400.87 crore.

Filing to action

What to do with a filing like this

Fusion Finance Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Fusion Finance Limited. Read the original for the full detail.

View original filing